HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kenjiro Sawada Selected Research

Iron

1/2022Safety and efficacy of Ninjin'yoeito along with iron supplementation therapy for preoperative anemia, fatigue, and anxiety in patients with gynecological disease: an open-label, single-center, randomized phase-II trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kenjiro Sawada Research Topics

Disease

66Neoplasms (Cancer)
03/2024 - 11/2002
36Ovarian Neoplasms (Ovarian Cancer)
04/2024 - 11/2002
14Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2023 - 07/2014
12Neoplasm Metastasis (Metastasis)
03/2024 - 12/2002
10Carcinoma (Carcinomatosis)
09/2018 - 04/2005
7Adenocarcinoma
01/2023 - 06/2011
6Carcinogenesis
01/2023 - 02/2008
5Ovarian Epithelial Carcinoma
06/2023 - 11/2018
5Endometrial Neoplasms (Endometrial Cancer)
03/2022 - 02/2015
5Ascites
01/2015 - 01/2005
4Osteoporosis
01/2017 - 11/2002
4Hypoxia (Hypoxemia)
05/2015 - 10/2004
3Postmenopausal Osteoporosis
01/2020 - 06/2003
3Infections
03/2016 - 02/2007
2Uterine Neoplasms (Uterine Cancer)
03/2022 - 01/2018
2Endometriosis
01/2022 - 08/2016
2Chorioamnionitis
03/2016 - 11/2013
2Inflammation (Inflammations)
03/2016 - 11/2013
1Carcinosarcoma
03/2024
1Pancreatic Fistula (Pancreatic Fistulas)
03/2024
1Thrombosis (Thrombus)
05/2023
1Chromosome Aberrations (Chromosome Abnormalities)
01/2023
1Genomic Instability
01/2023
1Anemia
01/2022
1Fatigue
01/2022
1Diarrhea
09/2021

Drug/Important Bio-Agent (IBA)

8MicroRNAs (MicroRNA)IBA
01/2020 - 05/2013
8Proteins (Proteins, Gene)FDA Link
08/2019 - 11/2002
8IntegrinsIBA
01/2019 - 02/2007
7Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2021 - 07/2014
5PlatinumIBA
10/2019 - 12/2015
5Cisplatin (Platino)FDA LinkGeneric
11/2018 - 09/2009
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2016 - 03/2007
5rho-Associated KinasesIBA
12/2009 - 11/2002
5lysophosphatidic acidIBA
12/2009 - 11/2002
5Tyrosine (L-Tyrosine)FDA Link
04/2007 - 11/2002
4Paclitaxel (Taxol)FDA LinkGeneric
05/2023 - 01/2015
4Indicators and Reagents (Reagents)IBA
01/2021 - 06/2011
4Neutralizing AntibodiesIBA
03/2019 - 07/2014
4Interleukin-6 (Interleukin 6)IBA
01/2019 - 11/2013
4Alendronate (Alendronate Sodium)FDA LinkGeneric
01/2009 - 11/2002
3Small Interfering RNA (siRNA)IBA
04/2024 - 02/2007
3Bevacizumab (Avastin)FDA Link
10/2023 - 08/2010
3Estrogens (Estrogen)FDA Link
01/2023 - 01/2018
3Mevalonic Acid (Mevalonate)IBA
01/2021 - 11/2002
3Irinotecan (Camptosar)FDA LinkGeneric
01/2019 - 06/2014
3Biomarkers (Surrogate Marker)IBA
09/2018 - 01/2014
3Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
10/2017 - 02/2007
3Phosphotransferases (Kinase)IBA
05/2016 - 02/2007
3Messenger RNA (mRNA)IBA
04/2009 - 10/2004
3Diphosphonates (Bisphosphonates)IBA
01/2005 - 11/2002
2Immunoglobulin G (IgG)IBA
10/2023 - 04/2008
2Plasminogen Activator Inhibitor 1IBA
10/2023 - 10/2017
2RNA (Ribonucleic Acid)IBA
10/2023 - 07/2022
2DNA (Deoxyribonucleic Acid)IBA
01/2023 - 02/2010
2Dinoprostone (PGE2)FDA Link
12/2020 - 11/2018
2TOR Serine-Threonine KinasesIBA
12/2020 - 09/2009
2YM 529IBA
01/2020 - 01/2017
2PM 01183IBA
10/2019 - 01/2016
2LipidsIBA
08/2019 - 02/2015
2Celecoxib (Celebrex)FDA Link
01/2019 - 11/2018
2VitronectinIBA
11/2018 - 10/2017
2taxaneIBA
10/2018 - 12/2017
2Raloxifene Hydrochloride (Evista)FDA Link
01/2017 - 02/2015
2CytokinesIBA
03/2016 - 11/2013
2Antineoplastic Agents (Antineoplastics)IBA
01/2016 - 12/2009
2Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
01/2015 - 11/2013
2TrabectedinIBA
06/2014 - 07/2011
2EverolimusFDA Link
07/2011 - 09/2009
2Oxygen (Dioxygen)IBA
09/2009 - 10/2004
2Cadherins (E-Cadherin)IBA
09/2009 - 04/2008
2Peptide Hydrolases (Proteases)FDA Link
02/2008 - 02/2007
2geranylgeranylacetone (teprenone)IBA
04/2007 - 04/2005
2NitrogenIBA
01/2005 - 11/2002
1AmylasesFDA Link
03/2024
1edoxabanIBA
05/2023
11,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
01/2023
1Galectin 3 (LGALS3)IBA
01/2022
1IronIBA
01/2022
1Asu(1,6)- argipressin (VAS-A)IBA
01/2022
1Hemoglobins (Hemoglobin)IBA
01/2022
1ninjin'yoeitoIBA
01/2022
1Farnesyl-Diphosphate Farnesyltransferase (Squalene Synthase)IBA
01/2021

Therapy/Procedure

23Therapeutics
01/2022 - 12/2002
8Drug Therapy (Chemotherapy)
03/2024 - 01/2015
6Radiotherapy
12/2022 - 07/2014
6Hysterectomy
10/2017 - 01/2012
3Aftercare (After-Treatment)
01/2022 - 02/2015
2Lymph Node Excision (Lymph Node Dissection)
03/2022 - 02/2015
2Laparotomy
03/2022 - 03/2011
2Kampo Medicine (Kampo)
01/2022 - 01/2018
2Brachytherapy
05/2021 - 03/2019
2Combination Drug Therapy (Combination Chemotherapy)
10/2018 - 12/2017
2Splenectomy
12/2015 - 07/2014
1Colectomy
03/2024
1Gynecologic Surgical Procedures (Gynecologic Surgery)
03/2024
1Stents
03/2024
1Minimally Invasive Surgical Procedures
06/2023
1Adjuvant Chemotherapy
05/2023
1Chemoradiotherapy
09/2021